Friday, 6 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Aster DM Quality Care Investor Presentation: Key Takeaways

Q2 FY27 revenue INR 2,829 Cr (+19% YoY), Op EBITDA INR 678 Cr (+25%), margin 24.0% (+111 bps), normalised PAT INR 281 Cr (+34%). Post-merger synergies and bed expansion to 15,070.

Highlights
MarginsOp EBITDA margin 24.0%, +111 bps YoY; highest in series.
Demand visibilityOccupancy 68% (+335 bps); patient volume +12%; MVT revenue +36%.

Growth

Revenue +19% YoY driven by 12% patient volume growth; H1 revenue INR 5,429 Cr (+20%). Normalised PAT +34% in Q2.

Outlook

Adds 4,230 beds to 15,070 by FY30+, 53% greenfield; synergy runway INR 65 Cr annualised of INR 200 Cr.

Risks

Under-performing units (12.1% EBITDA margin) and merger-related exceptional costs excluded from normalised PAT.

Last quarter's promises, checked

Delivered

  • Volume 5–6% → 12% (= BEAT)
  • Raipur cancer centre mid-Aug → opened Q2 (= BEAT)
  • Beds >15,000 → 15,070 (= BEAT)

Partly delivered

  • 24–25% margin in 2–3 yrs → 24.0% Q2 (= PARTIAL)
  • INR 150–200 Cr synergies → 65 Cr annualised (= PARTIAL)

Missed

  • MVT growth >50% → +36% (= MISS)
  • 53% brownfield → 53% greenfield (= MISS)
Source

Investor Presentation filed with NSE, NSE: ASTERDM. Summary written with AI assistance from the document.

Read the document ↗

Aster DM Quality Care Ltd: key numbers

Share price
₹712.15
Market cap
₹62,076 Cr
Revenue (annual)
₹4,643 Cr
Net profit (annual)
₹388.1 Cr
P/E (TTM)
194.8×Sector 53.4×
Promoter holding
53.79%+13.40% QoQ
FII holding
12.26%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aster DM Quality Care Ltd

All →